No. of SSRI prescriptions | Exclusive use a | |||||
---|---|---|---|---|---|---|
Cases | Controls | Unadjusted OR b (95% CI) | Adjusted OR c (95% CI) | |||
n | (%) | n | (%) | |||
No use d (reference) | 1,442 | (84.8) | 14,415 | (84.7) | 1.00 | 1.00 |
Paroxetine | ||||||
1 to 23 | 57 | (3.8) | 482 | (3.2) | 1.18 (0.89, 1.56) | 1.17 (0.88, 1.55) |
≥24 | 11 | (0.73) | 89 | (0.6) | 1.24 (0.66, 2.32) | 1.20 (0.64, 2.25) |
Sertraline | ||||||
1 to 23 | 22 | (1.5) | 240 | (1.6) | 0.92 (0.59, 1.42) | 0.92 (0.59, 1.42) |
≥24 | 8 | (0.5) | 44 | (0.3) | 1.82 (0.85, 3.87) | 1.84 (0.86, 3.93) |
Fluoxetine | ||||||
1 to 23 | 38 | (2.6) | 483 | (3.2) | 0.79 (0.56, 1.10) | 0.79 (0.56, 1.10) |
≥24 | 1 | (0.7) | 134 | (0.9) | 0.82 (0.44, 1.52) | 0.81 (0.44, 1.51) |
Fluvoxamine | ||||||
1 to 23 | 18 | (1.2) | 174 | (1.2) | 1.03 (0.64, 1.69) | 1.02 (0.63, 1.67) |
≥24 | 4 | (0.3) | 30 | (0.2) | 1.33 (0.47, 3.79) | 1.33 (0.47, 3.77) |
Citalopram e | ||||||
1 to 23 | 9 | (0.6) | 133 | (0.9) | Not estimatable | Not estimatable |
≥24 | 0 | (0.0) | 9 | (0.1) |